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Abstract
Background: The American Diabetes Association and World Health Organization have recently adopted the HbA1c
measurement as one method of diagnostic criteria for diabetes. The change in diagnostic criteria has important implications
for diabetes treatment and prevention. We therefore investigate diabetes using HbA1c and glucose criteria together, and
assess the prevalent trend in a developing southern Chinese population with 85 million residents.
Methods: A stratified multistage random sampling method was applied and a representative sample of 3590 residents 18
years of age or above was obtained in 2010. Each participant received a full medical check-up, including measurement of
fasting plasma glucose, 2-hour post-load plasma glucose, and HbA1c. Information on history of diagnosis and treatment of
diabetes was collected. The prevalence of diabetes obtained from the present survey was compared with the data from the
survey in 2002.
Results: The prevalence of diabetes based on both glucose and HbA1c measurements was 21.7% (95% CI: 17.4%–26.1%) in
2010, which suggests that more than 1 in 5 adult residents were suffering from diabetes in this developing population. Only
12.9% (95% CI: 8.3%–17.6%) of diabetic residents were aware of their condition. The prevalence of pre-diabetes was 66.3%
(95% CI: 62.7%–69.8%). The prevalence of diabetes and pre-diabetes which met all the three diagnostic thresholds (fast
plasma glucose, 2 hour post-load plasma glucose, and HbA1c) was 3.1% and 5.2%, respectively. Diabetes and pre-diabetes
as determined by HbA1c measurement had higher vascular risk than those determined by glucose levels. The prevalence of
diabetes increased from 2.9% (95% CI: 2.0%–3.7%) in 2002 to 13.8% (95% CI: 10.2%–17.3%) in 2010 based on the same
glucose criteria.
Conclusions: Our results show that the diabetes epidemic is accelerating in China. The awareness of diabetes is extremely
low. The glucose test and HbA1c measurement should be used together to increase detection of diabetes and pre-diabetes.
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Introduction
The fasting plasma glucose (FPG) test and the oral glucose
tolerance test (OGTT) are the most common methods for
screening and diagnosing diabetes. It has been debated for several
decades whether the glycated haemoglobin A1c (HbA1c) test, a
standard monitoring test for the control of diabetes, could be used
to diagnose diabetes. HbA1c level serves as a biomarker to capture
longer-term glycaemic exposure over time and is more intimately
related to the risk of complications than a single or episodic
measurement of glucose levels [1]. Concurrent with the improve-
ment and standardisation of the glycated haemoglobin A1c
(HbA1c) assay, an International Expert Committee in 2009
recommended that diabetes could be diagnosed when the HbA1c
level is more than 6.5%, provided it is measured using the
standardised assay method [1]. The American Diabetes Associa-
tion (ADA) subsequently adopted the use of the HbA1c
measurement as one method of diagnostic criteria in 2010 [2],
as did the World Health Organization (WHO) in 2011 [3].
The change in diagnostic criteria has important clinical and
public health implications. The inclusion of HbA1c will increase
the feasibility and dissemination of diabetes screening because it
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37260eliminates the need for fasting before testing. A large number of
people previously considered to be healthy would be reclassified as
diabetic [4]. In China, several large-scale surveys on diabetes have
been conducted [5,6,7,8]. The results show that the prevalence of
diabetes has increased markedly in last two decades. It is thought
that the rapid economic development and the aging population in
China have contributed to this increased prevalence. The latest
nationwide survey by Yang et al. in 2007 showed that the
prevalence of diabetes in China had reached 9.7% [7]. However,
all the previous surveys did not include the HbA1c measurement,
which means they may have overlooked a substantial part of the
population with diabetes or at high risk for diabetes and
cardiovascular disease.
Guangdong is a province located in southern China with a
population of 85 million residents [9]. The capital is Canton,
which is approximately 180 kilometres north of Hong Kong.
Guangdong was the first province where the Chinese leader Deng
Xiao Ping started economic reform and open policy in 1979.
When compared with other inland provinces, Guangdong is more
economically developed and urbanised. The diabetes epidemic in
Guangdong may be more pronounced and may have emerged
because of the accompanying economic development and lifestyle
transition. Data about diabetes in this province may provide
information to aid in the development of disease prevention and
intervention programmes for the inland provinces of China and
other areas with rapid economic development.
We conducted the Guangdong Health Survey 2010 (GHS 2010)
to investigate diabetes and pre-diabetes using the glucose and
HbA1c criteria together. To assess the prevalent trend of diabetes
in this developing population, we compared the data we obtained
in this survey with the data from the Guangdong Nutrition and
Health Survey 2002 (GNHS 2002) [10,11].
Methods
The GHS 2010 was conducted by the Guangdong Province
Centre for Disease Control and Prevention (CDC) from October
to December, 2010. Approval was obtained from the Ethics
Committee of the China Centre for Disease Control. All
participants gave written informed consent prior to the survey.
Stratified multistage cluster sampling with probability proportional
to size method was used for sampling in this survey. Briefly, the
cities and counties of the province were categorised into four strata
(large cities, small to medium cities, class 1 and class 2 rural areas)
based on their levels of economic development as identified by the
central government of China. The first stage of systematic
sampling was conducted in each stratum. One district from the
large cities, two districts from the small to medium cities, two
counties from the class 1 rural areas and one counties from the
class 2 rural counties were randomly selected based on population
size. The second stage of sampling was subsequently conducted in
each of the selected districts or counties: four neighbourhoods
(urban) or townships (rural) were sampled from each of the
selected districts or counties using the same systematic random
sampling methods as that in the first stage. In the third stage, three
residential committees (urban) or villages (rural) were sampled
from each of the selected neighbourhood or townships using the
same systematic random sampling methods as those in the first and
second stages. In the fourth stage, all the households in the
sampled residential committees (urban) or villages (rural) were
grouped into clusters containing at least 50 households geograph-
ically, with one of the clusters randomly selected. In the fifth stage,
50 households were randomly sampled from each selected cluster,
and one resident 18 years of age or above from each sampled
household was selected with the Kish Grid method. If there were
no residents 18 years of age or above in the selected household or
the selected resident did not agree to participate in the survey, the
household was replaced with a household nearby (526 [14.7%]
households were replaced). Therefore, a total of 3600 households
with 3600 residents aged 18 years or above were sampled in the
GHS 2010. Among those, we collected complete data on 3590
participants, which were included in the present analysis.
A central survey site was set up in each selected cluster, and the
participants were interviewed and received health examinations
on-site. All interviews and examinations were conducted following
standard protocols by physicians who received training specifically
for the GHS 2010. The questionnaire collected a wide range of
information including demographic, lifestyle, and family charac-
teristics and personal disease histories. Information related to the
history of the diagnosis and treatment of diabetes was also
collected in the interview. Weight and height measurements of the
participants were taken with light indoor clothing and without
shoes. Body mass index (BMI) was calculated as weight in
kilogrammes divided by the square of height in metres. The blood
pressure measurement was taken in accordance with the 1999
World Health Organization/International Society of Hyperten-
sion guidelines on hypertension [12]. Three consecutive readings
of blood pressure were taken using the right arms of participants
after the participant rested in a seated position for 5 minutes. The
average of the 2 final readings was used for analysis.
Venous blood samples were drawn in the morning after an
overnight fast using vacutainer tubes. After the fasting blood
sample was drawn, each participant had a 75 g oral glucose
tolerance test. The FPG and the 2-hour post-load plasma glucose
(2-h PG) were measured using a spectrophotometer 721/722 with
the glucose oxidase method. The finger-stick capillary whole blood
sample was collected using the Haemoglobin Capillary Collection
System (HCCS) and shipped on cold packs to the Shanghai
Institute of Endocrine and Metabolic Diseases in Shanghai, China,
where the laboratory has been certified by National Glycohemo-
globin Standardization Program (NGSP) for HbA1c measurement
[13]. Additional plasma samples were stored in airtight tubes at
280uC prior to shipment on dry ice to the national test centre
(Shanghai Ruijin Hospital) for the measurement of the lipids and
insulin.
Diabetes and pre-diabetes in the present study were defined
based on the criteria recommended by the ADA [14]. Previous
diagnosis of diabetes was defined as self-reported doctor-diagnosed
diabetes in the interview. New diagnosis of diabetes was given if
the participant had the following test results: 1) they had a FPG of
$7.0 mmol/l, 2) they had a 2-h PG of $11.1 mmol/l, or 3) they
had an HbA1c level of $6.5%. Diabetes was confirmed if the
participants were diagnosed with diabetes if any two out of the
three tests (the FPG, the 2-h PG and the HbA1c) were both above
the diagnostic thresholds. Pre-diabetes was defined if the
participants had any following conditions: 1) a FPG between 5.6
to 6.9 mmol/l (Impaired Fasting Glucose [IFG]), 2) a 2-h PG
between 7.8 to 11.0 mmol/l (Impaired Glucose Tolerance [IGT]),
or 3) an HbA1c level between 5.7 to 6.4%.
To ascertain the level of change in the diagnoses of diabetes in
this developing population, we compared the present study with
GNHS 2002 [10,11,15]. The GNHS 2002 corresponded with the
China National Nutrition and Health Survey 2002 (NNHS 2002),
and the details have been described elsewhere [8,11,15,16]. The
GNHS 2002 used a similar sampling method and recruited a total
of 6713 participants 18 years of age or above [11,15]. The FPG
test was performed for all participants, and the 2-h PG test was
only performed for those who had an IFG [11]. The glucose
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the same method used in the GHS 2010. The HbA1c levels were
not measured in the GNHS 2002.
The GHS 2010 and the GNHS 2002 adopted a stratified
multistage cluster sampling design including all men and women
18 years of age or above. All the data analyses were performed
using SAS software, version 9.2 (SAS Institute, Cary, NC, USA).
In a manner similar to our previous survey analysis for the U.S.
National Health and Nutrition Examination Survey (NHANES)
and GNHS 2002 [11,15,17], the survey design parameters,
including weight, stratum and cluster, were incorporated into all
the analyses. The weight was derived from the 2000 census data
and the associated administrative data. The non-response infor-
mation was also incorporated into the weight parameter. PROC
SURVEYMEANS and PROC SURVEYFREQ were used for the
calculation of the means and the prevalence. The means and the
prevalence calculated in this study correspond to the overall
estimates for the population of people 18 years of age or above in
the Guangdong province. PROC SURVEYREG and PROC
SURVEYLOGISTIC were used to assess the differences between
categories. Two-sided p values of less than 0.05 were considered
statistically significant. The 95% confidence intervals were
calculated and presented in the present study. The domain
statement was used for the subpopulation analyses.
Results
The mean age of the population was 50.1 (42.3, 58.0). Table 1
shows the general demographic and vascular characteristics of the
populations stratified by sex and region. Women had significant
lower blood pressure levels, triglyceride levels, education levels,
smoking rates, and rates of alcohol consumption and higher HDL
levels than men (all p,0.05). The rural population had a
significantly higher prevalence of smoking than the urban
population (p,0.001).
Table 2 shows the prevalence of normal healthy people, those
with pre-diabetes and those with diabetes in this southern Chinese
population stratified by sex, area and age. For healthy residents,
older age was significantly associated with a lower prevalence of
healthy residents (p=0.004). Men had a lower prevalence of
healthy residents than women (p,0.001). There was no significant
difference between people from urban regions and people from
rural regions (p=0.39).
As for pre-diabetes, older age was significantly associated with a
higher prevalence (p=0.027). There was no difference between
men and women (p=0.94), but the rural population had a higher
prevalence than the urban population, with borderline significance
(p=0.068).
As for diabetic residents, men generally had a higher prevalence
than women (p=0.013 for diagnosed diabetes, p=0.0024 for
newly diagnosed diabetes, p,0.001 for confirmed diabetes, and
p,0.001 for all diabetes), and the urban population had a higher
prevalence than those in the rural region (p=0.006 for diagnosed
diabetes, p=0.021 for newly diagnosed diabetes, p,0.001 for
confirmed diabetes, and p=0.0028 for all diabetes). Older age was
associated with a higher prevalence of diabetes (p values ranged
from ,0.001 to 0.013).
Figure 1 shows discordance in the prevalence of newly
diagnosed diabetes and pre-diabetes as determined using different
diagnostic approaches. The largest proportion of diabetes and pre-
diabetes were determined by HbA1c measurement. For the 654
newly diagnosed diabetes patients, 311 were diagnosed by glucose
levels (FPG, and/or 2-h PG), 225 were diagnosed by HbA1c
measurement, and 118 were diagnosed by both. Only 54 diabetes
patients (3.1% of the population) simultaneously had a FPG of
$7.0 mmol/l, a 2-h PG of $11.1 mmol/l, and an HbA1c level of
$6.5%. For the 2385 pre-diabetes, 596 were diagnosed by glucose
levels (FPG, and/or 2-h PG), 687 were diagnosed by HbA1c
measurement, and 1102 were diagnosed by both. Only 181 pre-
diabetes (5.2% of the population) simultaneously had an IFG, an
IGT, and an HbA1c level between 5.7 to 6.4%.
Table 3 shows the comparison of vascular risk factors for
diabetes determined by glucose and HbA1c levels. Compared to
the diabetes by glucose, patients by HbA1c were generally older,
and had higher BMI, waist circumference, blood pressure, lipids
(except for HDL-cholesterol) and insulin levels. Similar results
were observed for pre-diabetes (Table 3). Table 4 presents the
prevalence of diabetes in the GNHS 2002 and the GHS 2010
using different diagnostic approaches. For the GNHS 2002, the
prevalence of diabetes by self-reported diagnosis, self-reported
diagnosis/FPG test, and self-reported diagnosis/FPG test/2-h PG
test for those with an IFG were 1.4%, 2.9% and 2.9%,
respectively. For the GHS 2010, the corresponding figures were
2.8%, 11.9%, and 13.8% respectively. If all participants had 2-h
PG test, the prevalence of diabetes was 14.6%. The prevalence of
diabetes increased to 21.7% if all methods were used for diagnosis
(i.e., self-reported diagnosis, FPG test, 2-h PG test, and HbA1c
measurement).
Discussion
The results of the representative, population-based GHS 2010
show that the prevalence of diabetes based on glucose levels and
the HbA1c criterion is alarmingly high at 21.7% in this developing
southern Chinese population, which suggests that more than 1 in 5
adults 18 years of age and above are suffering from diabetes. This
translates to a total of 13.1 million adults having diabetes in the
Guangdong province, which has a population of 85 million
residents. This is in conjunction with an extremely low awareness
of diabetes in this region, with only 12.9% diabetic residents
knowing that they had the condition. The prevalence of pre-
diabetes in this population was 66.3%, which translates to
approximately 40.0 million adult residents who are at risk of
diabetes and cardiovascular disease. Our results also suggest that
the glucose test and the HbA1c measurement taken together can
significantly increase the detection of diabetes and pre-diabetes
among Chinese residents. Using only one single method to screen
and diagnose diabetes in large general populations is likely
underestimate the diabetic situation.
The prevalence of diabetes in China was relatively low before
the year 2000 but has increased dramatically in last decade. In
1994, a national survey of the Chinese population between 25 to
64 years of age showed that the prevalence of diabetes and IFG
was 2.5% and 3.2%, respectively [5]. Gu et al. conducted the
International Collaborative Study of Cardiovascular Disease in
Asia in 2001, and their results show that the prevalence of diabetes
and IFG among Chinese people between 35 to 74 years of age was
5.5% and 7.3%, respectively [6]. The results of the National
Nutrition and Health Survey 2002 (NNHS 2002) showed that the
national prevalence of diabetes and IFG was 2.7% and 4.9% for
Chinese people 20 years of age or above, respectively [8].
However, the age-standardised prevalence of diabetes in large
cities reported in the NNHS 2002 was 7.8%, which was already
close to the prevalence of 9.3% reported in the NHANES 1999–
2002 in the U.S. [8,18]. The results from the survey by Yang et al.
conducted in 2007 showed that the prevalence of diabetes and
IFG reached 9.7% and 15.5% nationwide [7]. All of these studies
applied the glucose criteria for the diagnosis of diabetes and IFG,
Diabetes Diagnosed by HbA1c and Glucose in China
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participants. In the present study, the FPG test and the 2-h PG test
were applied to all participants. The prevalence of diabetes and
IFG based on FPG and 2-h PG were 14.6% and 25.3%,
respectively. It is astonishing that the prevalence of diabetes based
on the same diagnostic method increased from 2.9% in 2002 to
13.8% in 2010 in this southern Chinese population (Table 4).
Furthermore, the prevalence of diabetes and pre-diabetes based on
the glucose and HbA1c criteria in the present study were 21.7%
and 66.3%, respectively. Though our sample is only representative
for the southern Chinese population of 85 million residents in the
GHS 2010, these results suggest that the diabetes epidemic is
accelerating in China.
The prevalence of pre-diabetes in this population is trembling.
Approximately 40.0 million adult residents have at least one of the
following three conditions: IFG, IGT, or an HbA1c level between
5.7%–6.4%. Studies have shown that 25%–40% individuals with
IFG or IGT will develop diabetes over the next 3 to 8 years
[19,20]. The HbA1c level was a strong predictor of subsequent
diabetes and cardiovascular events [21], and individuals with an
HbA1c value between 5.5% and 6.5% had a substantial increased
risk for developing diabetes within 5 years [22,23].
Rapid economic development and urbanization, an aging
population and a lifestyle transition with a consequent obesity
epidemic are likely the major contributors to the astonishing
increase of diabetes and pre-diabetes in this population in last
decade [24]. The data from our GNHS 2002 study show that the
mean age of the adult residents 18 years of age or above in this
population was 44.1 years, while it was 50.1 years in the GHS
2010. The prevalence of obesity, especially central obesity,
increased dramatically in the last decade. The mean waist
circumference was 75.0 cm in the year 2002, while it was
79.8 cm in the year 2010. Furthermore, the increased magnitudes
are more prominent in the rural regions than those in the urban
regions. In 2002, the mean waist circumference was 73.1 cm for
the rural population and 77.0 cm for the urban population, while
in 2010, the corresponding figures increased to 79.7 cm and
79.9 cm, respectively. Similar changes were also observed for
other risk factors, including BMI, lipids and blood pressure (data
not shown here). Our results have shown that the rural population
had a higher prevalence of pre-diabetes than the urban population
(Table 2). In addition to the dramatic increase in vascular risk,
studies have shown that the Asian populations have a higher
prevalence of diabetes and are more likely to develop diabetes
Table 1. Demographic and vascular characteristics by area and gender in the southern Chinese adults 18 years of age or above,
2010.
Urban region Rural region
Men (n=786) Women (n=1005) p Men (n=835) Women (n=964) p
Age (years) 51.9 (44.3, 59.5) 50.5 (42. 9, 58.2) 0.4 50.1 (35.3, 64.8) 49.0 (39.0, 59.0) 0.0083
Age group (years)
18–39 31.7 (28.3, 35.1) 32.4 (31.7, 33.1) 0.34 31.5 (26.0, 37.1) 32.3 (31.3, 33.2) 0.56
40–59 50.3 (49.8, 50.8) 50.2 (50.2, 50.2) 0.56 50.2 (50.0, 50.3) 49.5 (46.4,52.5) 0.38
60 or above 69.3 (65.0, 73.6) 68.9 (65.1, 72.7) 0.21 67.6 (65.5, 69.8) 68.0 (67.0, 68.9) 0.33
Body mass index (kg/m
2) 23.4 (21.2, 25.6) 23.3 (21.4, 25.2) 0.46 22.8 (22.8, 22.9) 22.5 (21.2, 23.8) 0.37
Waist circumference (cm) 82.5 (75.2, 89.7) 78.0 (74.9, 81.1) 0.021 81.6 (77.4, 85.7) 78.2 (66.8, 89.7) 0.15
Fasting plasma glucose
(mmol/L)
6.4 (5.5,7.3) 6.3 (5.7, 6.8) 0.18 5.8 (5.1, 6.5) 5.8 (4.7, 6.9) 0.66
2-hour post-load plasma
glucose (mmol/L)
6.9 (6.9, 6.9) 6.9 (6.4, 7.5) 0.81 7.0 (6.2, 7.9) 7.0 (6.8, 7.1) 0.69
Fasting insulin (mmol/L)* 5.5 (4.6, 6.6) 6.2 (4.6, 8.3) 0.02 5.2 (3.1, 8.6) 5.6 (3.9, 8.1) 0.11
2-hour post-load insulin
(mmol/L)*
21.3 (18.9, 24.1) 26.9 (25.5, 28.4) 0.0024 21.8 (4.8, 99.5) 23.3 (8.6,63.3) 0.63
HOMA-IR levels* 1.52 (1.13, 2.06) 1.69 (1.17, 2.46) 0.015 1.29 (0.91, 1.85) 1.40 (1.14, 1.71) 0.13
HbA1c levels (%) 6.1 (5.7, 6.5) 6.0 (5.8, 6.2) 0.45 6.0 (6.0,6.1) 6.0 (5.6, 6.3) 0.47
Systolic blood pressure
(mmHg)
135 (132, 138) 128 (128, 129) 0.0026 133 (122, 144) 128 (119, 137) 0.0016
Diastolic blood pressure
(mmHg)
82 (79, 86) 80 (79, 80) 0.032 81 (78, 85) 79 (77, 81) 0.0089
Total cholesterol (mmol/L) 4.3 (4.0, 4.5) 4.5 (4.1, 4.9) 0.12 4.2 (4.1, 4.2) 4.2 (4.0, 4.3) 0.72
Triglyceride (mmol/L) 1.5 (1.3, 1.7) 1.2 (0.7, 1.7) 0.033 1.5 (1.2, 1.7) 1.2 (1.0, 1.3) 0.048
HDL-cholesterol (mmol/L) 0.97 (0.77, 1.17) 1.14 (1.01, 1.28) 0.015 0.99 (0.95, 1.02) 1.08 (1.02, 1.13) ,0.001
LDL-cholesterol (mmol/L) 2.49 (2.38, 2.61) 2.61 (2.34, 2.88) 0.27 2.37 (2.33, 2.40) 2.36 (2.30, 2.43) 0.85
Education
(%, ,primary school)
27.1 (0.0, 55.1) 34.9 (15.5,54.3) 0.0052 32.1 (0.0, 69.9) 46.0 (21.7, 70.3) ,0.001
Smoking rates (%) 45.1 (37.0, 53.2) 1.6 (0.0, 3.3) ,0.001 51.9 (47.9, 55.9) 0.6 (0.6, 0.6) ,0.001
Alcohol consumption
rates (%)
47.8 (44.2, 51.3) 22.2 (21.8, 22.7) ,0.001 46.1 (28.1, 64.2) 18.6 (3.5, 33.7) ,0.001
*Geometric means.
doi:10.1371/journal.pone.0037260.t001
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fact that Asians have a smaller body mass index [25,26,27]. This
may also partly explain the steep increase in diabetes in our
population in last decade.
The high prevalence of diabetes and pre-diabetes in the present
study are also related to the thorough investigation using the
glucose and HbA1c tests together. The FPG test plus the OGTT is
currently the most common approach for screening diabetes in the
general population. However, the 1999 WHO guidelines only
recommend the OGTT for those patients with IFG. Our GHNS
2002 study showed that the FPG plus the 2-h PG test, restricted for
those people with IFG, did not increase the detection rate of
diabetes (Table 4), as the prevalence of IFG was low in the
population in the year 2002, and only 106 participants received
the 2-h PG test, which resulted in little increase in the detection
rate of diabetes. In the present study, the 2-h PG test restricted to
those people with IFG diagnosed an additional 1.9% of residents
as diabetic. The 2-hour PG test applied for those participants
Table 2. The prevalence of normal healthy people, people with pre-diabetes and people with diabetes stratified by age, sex and
area in the southern Chinese adults 18 years of age or above, 2010.
Category Total Age group (years)
18–39 40–59 60 or above
Healthy residents* (n=452)
All 12.0 (4.1, 19.9) 16.0 (81.5, 86.6) 11.6 (3.2, 19.9) 9.0 (0.0, 18.2)
Sex: Men 9.8 (2.4, 17.2) 12.7 (11.4, 14.1) 9.1 (0.5, 17.7) 8.6 (0.2, 17.1)
Women 13.7 (5.2, 22.3) 18.3 (12.7, 23.8) 13.4 (5.3, 21.5) 9.4 (0.0, 19.2)
Area: Urban 10.3 (1.7, 18.8) 18.0 (16.7,19.2) 9.0 (0.0,21.9) 6.6 (0.0, 18.6)
Rural 13.2 (1.3, 25.1) 14.8 (9.2,20.5) 13.5 (2.1, 24.7) 10.7 (0.0, 26.1)
Pre-diabetic residents (n=2385)
All 66.3 (62.7, 69.8) 67.7 (59.1, 76.4) 67.4 (65.2, 69.6) 62.3 (53.6, 71.0)
Sex: Men 66.2 (62.3, 70.2) 65.8 (55.0, 76.5) 68.0 (64.9, 71.1) 63.3 (49.7, 76.9)
Women 66.3 (62.1, 70.5) 69.2 (54.2, 84.2) 67.0 (64.2, 69.8) 61.4 (52.4, 70.4)
Area: Urban 64.5 (59.6, 69.4) 66.3 (47.0, 85.7) 66.3 (61.4, 71.2) 59.0 (44.5, 73.5)
Rural 67.5 (62.6, 72.4) 68.5 (58.6, 78.4) 68.2 (66.9,69.5) 64.7 (53.9, 75.4)
Diabetic residents
Diagnosed (n=99)
All 2.8 (1.3,4.3) 1.1 (0.0, 3.8) 2.2 (1.9, 2.6) 5.8 (4.0, 7.6)
Sex: Men 3.7 (0.3, 7.1) 2.2 (0.0, 8.9) 2.7 (1.8, 3.7) 6.7 (3.1, 10.4)
Women 2.2(2.1, 2.2) 0.3 (0.05, 0.5) 1.9 (1.3, 2.4) 4.9 (3.0, 6.9)
Area: Urban 4.4 (4.3, 4.5) 0.9 (0.0, 3.3) 3.9 (3.6, 4.3) 8.5 (1.6, 15.4)
Rural 1.7 (0.0, 4.3) 1.2 (0.0, 5.4) 1.0 (0.1, 1.9) 3.9 (1.6, 6.2)
Newly diagnosed diabetes (n=654)
All 18.9 (15.9, 21.9) 15.2 (7.2, 23.3) 18.8 (12.8, 24.8) 22.9 (16.0, 29.8)
Sex: Men 20.3 (18.7, 21.9) 19.3 (14.4, 24.3) 20.2 (13.5, 26.9) 21.4 (11.6, 31.1)
Women 17.9 (13.6, 22.2) 12.3 (1.7, 22.9) 17.7 (12.4, 23.1) 24.3 (9.6, 39.1)
Area: Urban 20.8 (17.1, 24.6) 14.8 (0.0, 30.4) 20.8 (13.1,28.4) 25.9 (6.3, 45.5)
Rural 17.6 (13.2, 22.1) 15.5 (7.0, 23.9) 17.3 (8.1, 26.4) 20.8 (18.4, 23.1)
Confirmed diabetes (n=292)
All 8.1 (5.4, 10.7) 5.8 (3.0, 8.7) 7.8 (4.1, 11.4) 10.9 (6.7, 15.2)
Sex: Men 9.6 (6.1, 13.1) 8.1 (0.0, 18.0) 9.4 (5.8, 13.0) 11.3 (7.9, 14.7)
Women 6.9 (4.7,9.0) 4.2 (0.9, 7.4) 6.6 (2.9, 10.3) 10.6 (4.7, 16.6)
Area: Urban 11.8 (6.4, 17.2) 8.5 (2.4, 14.5) 11.3 (3.3, 19.3) 15.7 (0.7, 30.7)
Rural 5.5 (3.0, 8.0) 4.4 (2.9, 5.8) 5.2 (4.0, 6.4) 7.5 (4.1, 11.0)
All diabetes (n=753)
All 21.7 (17.4, 26.1) 16.3 (9.1, 23.5) 21.0 (14.6, 27.4) 28.7 (20.0, 37.3)
Sex: Men 24.0 (19.6, 28.3) 21.5 (11.8, 31.2) 23.0 (15.5, 30.5) 28.1 (19.5, 36.7)
Women 20.0 (15.7, 24.3) 12.5 (2.1, 23.0) 19.6 (14.2, 25.0) 29.2 (14.9, 43.6)
Area: Urban 25.2 (21.6, 28.8) 15.7 (0.0, 33.8) 24.7 (16.7,32.7) 34.4 (7.9, 60.8)
Rural 19.4 (12.4, 26.4) 16.7 (12.4, 20.8) 18.3 (8.3, 28.3) 24.6 (19.9, 29.3)
*Refers to residents with normoglycaemia and normal HbA1c levels.
doi:10.1371/journal.pone.0037260.t002
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(Table 4). In previous surveys, the 2-hour PG test was generally
applied to those participants with IFG for screening diabetes
except in the study by Yang et al. [5,6,7,8]. These surveys might
underestimate the prevalence of diabetes.
Until 2010, the diagnosis of diabetes was based solely on glucose
concentration. In contrast to glucose measurement, the HbA1c
test does not require a fasting sample; thus, it is more convenient.
However, the HbA1c criteria are relatively new, and there are still
concerns, including the standardised HbA1c measurement, a cut-
off point, different ethnic distributions and a discordance with the
glucose criteria [28,29,30], which could encumber the wide use of
the HbA1c test for diabetes screening and diagnosis. In our GHS
2010, when we applied the cut-off point of 6.3% as suggested by
Bao et al. for the Chinese population [31], the prevalence of
diabetes increased to 28.2%. Nonetheless, due to the proven
relationship of HbA1c levels with diabetes-related complications
and vascular diseases, a large number of people will be missed
without the HbA1c measurement even though they are suffering
from diabetes or at risk of diabetes and cardiovascular disease,
Figure 1. The prevalence of diabetes and pre-diabetes using different screening methods.
doi:10.1371/journal.pone.0037260.g001
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diabetes and pre-diabetes determined by HbA1c had higher
vascular risk than those determined by glucose levels (Table 3). In
our GHS 2010, based on the cut-off value of 6.5% recommended
by the ADA, the HbA1c criterion alone diagnosed 12.0% of
residents as diabetic (Figure 1) and added 7.1% residents as
diabetic, in addition to the patients diagnosed by the glucose
criteria and self-reporting (Table 4). Our results support the use of
both the glucose test and the HbA1c test together for diabetes
screening and diagnosis [23,30].
The strengths of our study include a representative sample that
targeted a large southern Chinese population of 85 million
residents and a thorough investigation on diabetic conditions using
all three screening and diagnosis approaches, including the FPG
test, the 2-h PG test and the standardised HbA1c measurement in
a NGSP-certified laboratory. We also assessed the diabetes trend
in this population by comparing the data from the GNHS 2002.
One limitation is that each test (the FPG, the 2-h PG and the
HbA1c) was performed once for each participant in the present
study, which limited us when calculating the accurate prevalence
of confirmed diabetes. Based on the ADA criteria, retesting is
suggested to confirm a diagnosis in a clinical setting if diabetes is
determined by one single test [14].
In summary, the prevalence of diabetes and pre-diabetes in the
Guangdong province as determined by the HbA1c test and the
Table 3. Vascular risk characteristics of diabetes and pre-diabetes determined by glucose and HbA1c levels in the southern
Chinese adults 18 years of age or above, 2010.
Diabetes Pre-diabetes
FPG and/or 2-h PG HbA1c p FPG and/or 2-h PG HbA1c p
(n=311) (n=225) (n=596) (n=687)
Age (years) 48.7 (39.5, 57.9) 55.5 (52.0, 58.9) 0.018 47.5 (43.1, 51.9) 50.0 (40.9, 59.5) ,0.001
Sex (male %) 46.2 (38.8, 53.6) 43.9 (38.8, 49.0) 0.42 44.6 (41.7, 47.6) 42.2 (31.2, 53.4) 0.47
Body mass index
(kg/m
2)
23.4 (19.0, 27.9) 25.4 (20.1, 30.7) ,0.001 23.1 (20.4, 25.8) 23.5 (20.7, 26.3) 0.0003
Waist circumference
(cm)
79.4 (71.1, 87.7) 84.5 (75.5, 93.6) ,0.001 75.2 (69.7, 80.6) 77.0 (70.3, 83.6) ,0.001
Systolic blood pressure (mmHg) 103 (98, 109) 109 (104, 115) ,0.001 101 (91, 111) 103 (93, 113) ,0.001
Diastolic blood pressure (mmHg) 75 (74, 77) 79 (76, 81) ,0.001 74 (65, 82) 75 (67, 83) ,0.001
Total cholesterol
(mmol/L)
4.17 (3.62, 4.72) 4.59 (4.05, 5.14) ,0.001 3.24 (2.59, 3.88) 3.76 (3.09, 4.42) ,0.001
Triglyceride (mmol/L) 1.53 (0.64, 2.42) 2.01 (1.29, 2.74) 0.0041 0.85 (0.51, 1.20) 1.09 (0.70, 1.49) 0.0068
LDL-triglyceride
(mmol/L)
2.14 (1.77, 2.51) 2.46 (2.16, 2.76) ,0.001 1.71 (1.25, 2.17) 2.06 (1.59, 2.53) ,0.001
HDL-cholesterol
(mmol/L)
1.08 (0.89, 1.26) 1.00 (0.81, 1.19) ,0.001 0.96 (0.77, 1.16) 1.00 (0.88, 1.13) ,0.001
Fasting insulin
(mmol/L)*
7.60 (6.05, 9.55) 8.71 (6.77, 11.21) ,0.001 6.53 (5.67, 7.50) 7.99 (6.91, 9.24) ,0.001
2-hour post-load insulin
(mmol/L)*
23.10 (7.32, 72.96) 29.89 (12.48, 71.58) 0.0011 21.79 (18.62, 25.50) 27.35 (18.92, 39.53) ,0.001
HOMA-IR levels* 2.60 (2.23, 3.03) 2.04 (1.53, 2.72) ,0.001 1.72 (1.37, 2.15) 1.78 (1.43, 2.21) 0.0080
Fasting plasma glucose
(mmol/L)
8.16 (6.60, 9.73) 5.34 (4.79, 5.88) ,0.001 5.92 (5.25, 6.58) 5.04 (4.28, 5.80) ,0.001
2-hour post-load plasma
glucose (mmol/L)
11.87 (8.00, 15.73) 5.61 (4.20, 7.02) 0.024 6.15 (5.50, 6.81) 5.12 (4.13, 6.11) ,0.001
HbA1c levels (%) 5.99 (5.34, 6.65) 7.58 (6.29, 8.88) ,0.001 5.28 (5.19, 5.37) 5.92 (5.81, 6.04) ,0.001
All variables were adjusted by age except for age and sex.
*geometric means.
doi:10.1371/journal.pone.0037260.t003
Table 4. The comparison of the prevalence of diabetes in
2002 and 2010 in the southern Chinese adults 18 years of age
and above.
Screening methods The GNHS 2002 The GHS 2010
n Diabetes n Diabetes
Self-reporting 102 1.4 (1.1, 1.8) 99 2.8 (1.3, 4.3)
Self-reporting/FPG * 193 2.9 (2.0, 3.7) 432 11.9 (6.2, 17.7)
Self-reporting/FG/partly
2-h PG {
193 2.9 (2.0, 3.7) 501 13.8 (10.2, 17.3)
Self-reporting/FG/all
2-h PG {
- - 528 14.6 (13.3, 15.9)
Self-reporting/FG/2-h
PG/HbA1c ||||
- - 753 21.7 (17.3, 26.1)
*: diabetes was diagnosed by self-reporting in an interview and with fasting
plasma glucose (FPG) test.
{: diabetes was diagnosed by self-reporting in an interview, with FPG test and
with 2-hour post-load plasma glucose (2-h PG) test for those with an IFG.
{: diabetes was diagnosed by self-reporting in an interview, with FPG test and
with 2-h PG test for all participants.
||||: diabetes was diagnosed by self-reporting in an interview, with FPG, with 2-h
PG test and with HbA1c measurement.
doi:10.1371/journal.pone.0037260.t004
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We estimate that a total of 13.1 million adult residents have
diabetes and that 40.0 million adult residents are at risk of
developing diabetes and cardio-vascular disease. The prevalence
of diabetes and pre-diabetes has increased dramatically within an
8-year period in the Guangdong province with rapid economic
development, which suggests that the diabetes epidemic is
accelerating in China. Our results suggest that the glucose and
the HbA1c approaches should be used together for the screening
and diagnosing of diabetes and pre-diabetes. One single approach
will underestimate the prevalence of diabetes and miss a
substantial proportion of the diabetic patients or adults at risk
for diabetes and vascular disease, who may require treatment and
care. The awareness of diabetes in this developing population is
extremely low. Urgent public health actions are needed to control
this worsening situation in China.
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